Moneycontrol PRO
thyrocare technologies
Jump to
97 Results Found
  • Apollo Hospitals’ digital plans resonate after PharmEasy-Thyrocare deal Jun 30, 2021 09:13 AM IST

    Apollo Hospitals’ digital plans resonate after PharmEasy-Thyrocare deal

    Apollo is reorganising its pharmacy and digital healthcare platform into a new unit. It plans to access investor capital and scale up the new subsidiary

  • Thyrocare Technologies share price falls 3% as IPO-bound PharmEasy acquires 66.1% stake Jun 28, 2021 11:10 AM IST

    Thyrocare Technologies share price falls 3% as IPO-bound PharmEasy acquires 66.1% stake

    API Holdings Ltd (API), the parent company of PharmEasy, announced the "signing of definitive documents to acquire 66.1 percent stake in Thyrocare from Dr A Velumani and affiliates at a price of Rs 1,300 per share aggregating to Rs 4,546 crore," an official statement noted.

  • PharmEasy is just what the doctor ordered for Thyrocare Jun 28, 2021 08:22 AM IST

    PharmEasy is just what the doctor ordered for Thyrocare

    Thyrocare has a lean cost structure. But compared to its major diagnostic peers, Thyrocare has lower on-ground (b2c) presence

  • Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y Jun 11, 2021 11:25 AM IST

    Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y

  • Thyrocare Techn Standalone March 2021 Net Sales at Rs 139.16 crore, up 48.64% Y-o-Y May 10, 2021 11:44 AM IST

    Thyrocare Techn Standalone March 2021 Net Sales at Rs 139.16 crore, up 48.64% Y-o-Y

  • Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y May 10, 2021 11:44 AM IST

    Thyrocare Techn Consolidated March 2021 Net Sales at Rs 146.84 crore, up 44.76% Y-o-Y

  • Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y Feb 02, 2021 09:11 AM IST

    Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y

  • Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y Nov 02, 2020 06:33 PM IST

    Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y

  • Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y Oct 30, 2020 09:11 AM IST

    Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y

  • Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher Aug 08, 2020 12:34 PM IST

    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher

    Prabhudas Lilladher is bearish on Thyrocare Technologies has recommended sell rating on the stock with a target price of Rs 307 in its research report dated August 04, 2020.

  • Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y Aug 03, 2020 09:21 AM IST

    Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y

  • Coronavirus | Thyrocare Technologies launches 'COVID Antibody Tests' Jul 03, 2020 09:20 PM IST

    Coronavirus | Thyrocare Technologies launches 'COVID Antibody Tests'

    The test kits and procedures have been approved by ICMR, and the company has made the test available pan India, Thyrocare said in a statement.

  • Thyrocare Techn Standalone March 2020 Net Sales at Rs 93.62 crore, down 3.77% Y-o-Y May 28, 2020 10:07 AM IST

    Thyrocare Techn Standalone March 2020 Net Sales at Rs 93.62 crore, down 3.77% Y-o-Y

  • Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher May 27, 2020 11:30 AM IST

    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher

    Prabhudas Lilladher is bearish on Thyrocare Technologies has recommended sell rating on the stock with a target price of Rs 307 in its research report dated May 27, 2020.

  • Thyrocare Tech, Dr Lal PathLabs rise 9% as govt allow private lab to do coronavirus testing Mar 18, 2020 11:24 AM IST

    Thyrocare Tech, Dr Lal PathLabs rise 9% as govt allow private lab to do coronavirus testing

    The total number of coronavirus cases in India rose to 147, with 10 fresh cases reported from various parts of the country.

  • Buy or Sell | Thyrocare Technologies could return 20% Dec 23, 2019 03:04 PM IST

    Buy or Sell | Thyrocare Technologies could return 20%

    Dinesh Rohira Founder and CEO of 5nance.com is positive on Thyrocare Technologies and expects the company to grow.

  • Buy Thyrocare Technologies; target of Rs 686: Prabhudas Lilladher Nov 13, 2019 04:53 PM IST

    Buy Thyrocare Technologies; target of Rs 686: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 686 in its research report dated November 08, 2019.

  • Buy Thyrocare Technologies; target of Rs 595: Prabhudas Lilladher Aug 19, 2019 02:03 PM IST

    Buy Thyrocare Technologies; target of Rs 595: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 595 in its research report dated August 14, 2019.

  • Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher Jul 12, 2019 05:18 PM IST

    Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 12.3 percent Y-o-Y (up 3.3 percent Q-o-Q) to Rs. 109.1 crore, according to Prabhudas Lilladher.

  • Thyrocare Techn Standalone March 2019 Net Sales at Rs 97.29 crore, up 8.06% Y-o-Y May 20, 2019 12:41 PM IST

    Thyrocare Techn Standalone March 2019 Net Sales at Rs 97.29 crore, up 8.06% Y-o-Y

  • Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher Apr 12, 2019 01:21 PM IST

    Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 35 percent Y-o-Y (up 35.5 percent Q-o-Q) to Rs. 130.5 crore, according to Prabhudas Lilladher.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher Feb 18, 2019 02:10 PM IST

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated February 12, 2019.

  • Thyrocare Techn Standalone December 2018 Net Sales at Rs 88.12 crore, up 13.21% Y-o-Y Feb 11, 2019 10:39 AM IST

    Thyrocare Techn Standalone December 2018 Net Sales at Rs 88.12 crore, up 13.21% Y-o-Y

  • Buy Thyrocare Technologies; target of Rs 796: Prabhudas Lilladher Nov 15, 2018 12:28 PM IST

    Buy Thyrocare Technologies; target of Rs 796: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 796 in its research report dated November 12, 2018.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher Aug 21, 2018 05:04 PM IST

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated August 14, 2018.

Sections
ISO 27001 - BSI Assurance Mark